Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+8.56%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
5.37%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$123M |
| 2 |
Intel
INTC
|
+$84.6M |
| 3 |
Prudential Financial
PRU
|
+$72.9M |
| 4 |
Lam Research
LRCX
|
+$64.5M |
| 5 |
SBA Communications
SBAC
|
+$61.7M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$104M |
| 2 |
Target
TGT
|
+$95.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$65.5M |
| 5 |
Intercontinental Exchange
ICE
|
+$59.4M |
Sector Composition
| 1 | Technology | 21.94% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
HBT Financial
HBT
$825M
| $943K | 0.01% |
54,136
-13,029
| -19% | -$227K |
|
|
NTST
752
NETSTREIT Corp
NTST
$1.72B
| $942K | 0.01% |
40,870
-59,712
| -59% | -$1.38M |
|
753
Texas Roadhouse
TXRH
$11.1B
| $941K | 0.01% |
+9,778
| New | +$941K |
|
754
Valhi
VHI
$463M
| $921K | 0.01% |
37,849
+14,254
| +60% | +$347K |
|
755
Carter Bankshares
CARE
$448M
| $917K | 0.01% |
73,280
+3,922
| +6% | +$49.1K |
|
756
Noodles & Co
NDLS
$30.9M
| $912K | 0.01% |
73,097
-2,948
| -4% | -$36.8K |
|
757
4D Molecular Therapeutics
FDMT
$326M
| $901K | 0.01% |
+37,417
| New | +$901K |
|
|
DHC
758
Diversified Healthcare Trust
DHC
$1.04B
| $900K | 0.01% |
215,358
+103,389
| +92% | +$432K |
|
|
INBX
759
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $899K | 0.01% |
32,664
+2,243
| +7% | +$61.7K |
|
760
Cidara Therapeutics
CDTX
$1.58B
| $891K | 0.01% |
22,053
-11,710
| -35% | -$473K |
|
761
Regional Management Corp
RM
$424M
| $888K | 0.01% |
19,091
+3,340
| +21% | +$155K |
|
762
C4 Therapeutics
CCCC
$193M
| $886K | 0.01% |
+23,413
| New | +$886K |
|
763
Piper Sandler
PIPR
$5.9B
| $881K | 0.01% |
6,799
-9,915
| -59% | -$1.28M |
|
764
Radiant Logistics
RLGT
$304M
| $879K | 0.01% |
126,782
+18,043
| +17% | +$125K |
|
|
SYNH
765
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $876K | 0.01% |
+9,786
| New | +$876K |
|
766
Meridian
MRBK
$177M
| $870K | 0.01% |
66,322
-4,802
| -7% | -$63K |
|
767
Spok Holdings
SPOK
$357M
| $864K | 0.01% |
89,794
| – | – |
|
|
JNCE
768
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $863K | 0.01% |
126,857
-1,128
| -0.9% | -$7.67K |
|
769
Assembly Biosciences
ASMB
$179M
| $856K | 0.01% |
18,375
-3,035
| -14% | -$141K |
|
770
Johnson & Johnson
JNJ
$429B
| $854K | 0.01% |
5,181
+2,432
| +88% | +$401K |
|
|
SIC
771
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $853K | 0.01% |
+90,767
| New | +$853K |
|
772
LSI Industries
LYTS
$715M
| $852K | 0.01% |
106,386
-30,681
| -22% | -$246K |
|
773
scPharmaceuticals
SCPH
$300M
| $847K | 0.01% |
138,604
-2,363
| -2% | -$14.4K |
|
774
Sinclair Inc
SBGI
$970M
| $840K | 0.01% |
+25,285
| New | +$840K |
|
775
Karyopharm Therapeutics
KPTI
$54.2M
| $839K | 0.01% |
+5,417
| New | +$839K |
|